Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Pati, Shibani ^a   Gerber, Michael H ^a   Menge, Tyler D ^a   Wataha, Kathryn A ^a   Zhao, Yuhai ^a   Baumgartner, John Adam ^a   Zhao, Jing ^a   Letourneau, Phillip A ^a   Huby, Maria P ^a   Baer, Lisa A ^a   Salsbury, John R ^a   Kozar, Rosemary A ^a   Wade, Charles E ^a   Walker, Peter A ^a   Dash, Pramod K ^a   Cox Jr , Charles S ^a   Doursout, Marie Francoise ^a   Holcomb, John B ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD68 ANTIGEN; CLAUDIN 1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 10; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; OCCLUDIN; OCCLUDIN 1; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A; CADHERIN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL INFILTRATION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; GAS EXCHANGE; HEMATOPOIETIC STEM CELL; HEMORRHAGIC SHOCK; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ADHERENCE; LUNG CAPILLARY; LUNG EDEMA; LUNG ENDOTHELIUM; LUNG FUNCTION; MEAN ARTERIAL PRESSURE; MESENCHYMAL STEM CELL; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PERICYTE; PERMEABILITY BARRIER; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; STOMACH MUSCLE; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; ANIMAL; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL LINE; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LUNG; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTIGENS, CD; BETA CATENIN; BONE MARROW CELLS; CADHERINS; CELL ADHESION; CELL LINE; CELLS, CULTURED; CHEMOKINE CCL3; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; LEUKOCYTES; LUNG; MALE; MESENCHYMAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80053282797     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025171     Document Type: Article

References (47)

1. Cinel I, Dellinger RP, (2007) Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20: 345-352.
2. Fein AM, Calalang-Colucci MG, (2000) Acute lung injury and acute respiratory distress syndrome in sepsis and septic shock. Crit Care Clin 16: 289-317.
3. Sinclair DG, Braude S, Haslam PL, Evans TW, (1994) Pulmonary endothelial permeability in patients with severe lung injury. Clinical correlates and natural history. Chest 106: 535-539.
4. Ware LB, Matthay MA, (2000) The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349.
5. Wheeler AP, Bernard GR, (2007) Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369: 1553-1564.
6. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, et al. (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30: 51-61.
7. Rocco TR Jr, Reinert SE, Cioffi W, Harrington D, Buczko G, et al. (2001) A 9-year, single-institution, retrospective review of death rate and prognostic factors in adult respiratory distress syndrome. Ann Surg 233: 414-422.
8. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, et al. (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
9. Qian H, Yang H, Xu W, Yan Y, Chen Q, et al. (2008) Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int J Mol Med 22: 325-332.
10. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441.
11. Gupta N, Su X, Popov B, Lee JW, Serikov V, et al. (2007) Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863.
12. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, et al. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 102: 11474-11479.
13. Uccelli A, Moretta L, Pistoia V, (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
14. Pati S, Matijevic N, Doursout MF, Ko T, Cao Y, et al. (2010) Protective effects of fresh frozen plasma on vascular endothelial permeability, coagulation, and resuscitation after hemorrhagic shock are time dependent and diminish between days 0 and 5 after thaw. J Trauma 69 (Suppl 1): S55-63.
15. Lampugnani MG, Dejana E, (2007) Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis. Thromb Res 120 (Suppl 2): S1-6.
16. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, et al. (2006) Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203: 1235-1247.
17. Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, et al. (2011) Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev 20: 89-101.
18. Grotz MR, Ding J, Guo W, Huang Q, Deitch EA, (1995) Comparison of plasma cytokine levels in rats subjected to superior mesenteric artery occlusion or hemorrhagic shock. Shock 3: 362-368.
19. Lee CC, Chang IJ, Yen ZS, Hsu CY, Chen SY, et al. (2005) Effect of different resuscitation fluids on cytokine response in a rat model of hemorrhagic shock. Shock 24: 177-181.
20. Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, et al. (2010) Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol 225: 341-352.
21. Aird WC, (2003) Endothelial cell heterogeneity. Crit Care Med 31: S221-230.
22. Crosby CV, Fleming PA, Argraves WS, Corada M, Zanetta L, et al. (2005) VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 105: 2771-2776.
23. Dejana E, Orsenigo F, Lampugnani MG, (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121: 2115-2122.
24. Pati S, Cavrois M, Guo HG, Foulke JS Jr, Kim J, et al. (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75: 8660-8673.
25. Sondeen JL, Dubick MA, Holcomb JB, Wade CE, (2007) Uncontrolled hemorrhage differs from volume- or pressure-matched controlled hemorrhage in swine. Shock 28: 426-433.
26. Chen J, Li Y, Wang L, Zhang Z, Lu D, et al. (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32: 1005-1011.
27. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, et al. (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18: 683-692.
28. Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, et al. (2009) Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 110: 1189-1197.
29. Bazzoni G, Dejana E, (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84: 869-901.
30. Diaz-Flores L, Gutierrez R, Varela H, Rancel N, Valladares F, (1991) Microvascular pericytes: a review of their morphological and functional characteristics. Histol Histopathol 6: 269-286.
31. Kerkar S, Speyer C, Tyburski J, Steffes C, (2001) Reactive oxygen metabolites induce a biphasic contractile response in microvascular lung pericytes. J Trauma 51: 440-445.
32. Sims DE, (1991) Recent advances in pericyte biology-implications for health and disease. Can J Cardiol 7: 431-443.
33. Andrae J, Gallini R, Betsholtz C, (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312.
34. Ball SG, Shuttleworth CA, Kielty CM, (2007) Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 11: 1012-1030.
35. Ball SG, Shuttleworth CA, Kielty CM, (2007) Platelet-derived growth factor receptor-alpha is a key determinant of smooth muscle alpha-actin filaments in bone marrow-derived mesenchymal stem cells. Int J Biochem Cell Biol 39: 379-391.
36. Kamouchi M, Ago T, Kitazono T, (2010) Brain Pericytes: Emerging Concepts and Functional Roles in Brain Homeostasis. Cell Mol Neurobiol.
37. Veevers-Lowe J, Ball SG, Shuttleworth A, Kielty CM, (2011) Mesenchymal stem cell migration is regulated by fibronectin through {alpha}5{beta}1-integrin-mediated activation of PDGFR-{beta} and potentiation of growth factor signals. J Cell Sci 124: 1288-1300.
38. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, et al. (2011) Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2: 27.
39. Fang X, Neyrinck AP, Matthay MA, Lee JW, (2010) Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285: 26211-26222.
40. Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, et al. (2010) Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138: 965-972.
41. Ware LB, Matthay MA, (2002) Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair. Am J Physiol Lung Cell Mol Physiol 282: L924-940.
42. Fleck A, Raines G, Hawker F, Trotter J, Wallace PI, et al. (1985) Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1: 781-784.
43. London NR, Zhu W, Bozza FA, Smith MC, Greif DM, et al. (2010) Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2: 23ra19.
44. Aggarwal S, Pittenger MF, (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822.
45. Pittenger MF, (2008) Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 449: 27-44.
46. Weiss DJ, Kolls JK, Ortiz LA, Panoskaltsis-Mortari A, Prockop DJ, (2008) Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 5: 637-667.
47. Guidot DM, Folkesson HG, Jain L, Sznajder JI, Pittet JF, et al. (2006) Integrating acute lung injury and regulation of alveolar fluid clearance. Am J Physiol Lung Cell Mol Physiol 291: L301-306.